Fujitsu and Technische Universitat Munchen Develop World's First Dna-Based Revolutionary Bio-Sensor Technology

Kawasaki, Japan and Duesseldorf, Apr 16, 2010 - (JCN Newswire) - Fujitsu Laboratories Ltd. and the Technische Universitat Munchen ("TUM", Technical University Munich) today announced the joint development of a completely novel bio-sensor technology. The new technology, the first of its kind in the world, works by inducing a cyclical motion in negatively charged DNA(1) and measuring its movement, to enable quick detection of proteins. The human body contains tens of thousands of different types of proteins, each playing an important role. By measuring fluctuations in proteins that are associated with certain diseases, it will be possible to offer diagnoses that are more accurate, enable earlier detection of the presence of diseases, and prescribe treatments that are more effective. As this technology can accurately measure proteins in just 1/100th the time of previous methods, it is expected to have a significant impact on health maintenance and disease prevention. With support from Fujitsu Laboratories, the team driving the technology at TUM will be commercializing it through the EXIST(2) incubation program run by the German Federal Ministry of Economics and Technology. Business plans centered on this new technology recently won two German business plan competitions(3), which recognized both the advanced technical achievement behind the technology and its strong commercial potential.